Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05206617
3 Year Follow up on ANO5 Patients
Sponsor: Rigshospitalet, Denmark
View on ClinicalTrials.gov
Summary
The aim of the study is to investigate progression in muscle affection in patients with pathogenic variants in the anoctamin 5 gene to: 1. investigate possible progression of disease over time 2. investigate good and reliable outcome measures
Official title: 3 Year Follow up on Patients With Pathogenic Anoctamin 5 Variants
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
17
Start Date
2018-01-01
Completion Date
2026-11-01
Last Updated
2025-04-06
Healthy Volunteers
No
Interventions
OTHER
No intervention - pure observational study
No intervention
Locations (1)
Copenhagen Neuromuscular Center
Copenhagen, Capital Region, Denmark